5Sliverman DH, Munakata JA, Ennes H, et al. Regional cerebral activity in normal and pathological perception of visceral pain. Gastroenterology, 1997,112(1) :64 - 72
6Mertz H, Morgan V, Tanneer G, et al. Regional cerebral activeation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention. Gastroenterology,2000,118(5) :842 - 8
7Monica Bose, Carole Nickols, Roger Feakins, et al. A Comparison of 5hydroxytryptamine Staining In Enterochromaffin Cells Betweem Irritable Bowel Syndrome And Other Gastrointestinal Disorders. Gut, 2000,47( Suppl Ⅲ ) :A210
8Fukudo S, Nomura T, Hongo M. Impact of corticotropin - releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut, 1998,42(6 ) :845 - 9
9Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroondoorine cells, T lymphocytes and increased gut permeability following acute campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut,2000,47(6) ;804- 11
6Wang YT, Kwok KF, Tan SM, el al. Comprehensive psychological intervention to improve outcome in functional gastrointestinal disorder: a cohort study[J].Singapore Med J,2015,56(7):385-392.
7Almquist E, TSrnblom H, Sitar e n M. Practical management of irritable bowel syndrome: a clinical review[J]. Minerva Gastroenterol Dietol, 2016,62(1):30-48.
8Chen YH, Chen XK, Yin XJ. Comparison of the therapeutic effects of electroacopuncture and orobiotics combined with deanxlt in treatinrdiarrhea-predominant irritable bowel syndrome[J].Zhongguo Zhong Xi Yi Jie He Za Zhi,2012,32(5):594-598.
10Andrae DA,Patrick DL,Drossman DA,et al.Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients[J].Health Qual Life Outcomes,2013,11:208.
